These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Folate-mediated drug delivery: effect of alternative conjugation chemistry. Leamon CP; DePrince RB; Hendren RW J Drug Target; 1999; 7(3):157-69. PubMed ID: 10680972 [TBL] [Abstract][Full Text] [Related]
6. Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. Atkinson SF; Bettinger T; Seymour LW; Behr JP; Ward CM J Biol Chem; 2001 Jul; 276(30):27930-5. PubMed ID: 11359781 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin. Sharma S; Podder SK; Karande AA Mol Cell Biochem; 1999 Oct; 200(1-2):133-41. PubMed ID: 10569193 [TBL] [Abstract][Full Text] [Related]
8. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. Lee RJ; Low PS J Biol Chem; 1994 Feb; 269(5):3198-204. PubMed ID: 8106354 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201 [TBL] [Abstract][Full Text] [Related]
10. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080 [TBL] [Abstract][Full Text] [Related]
11. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
12. High sensitivity of cultured human trophoblasts to ribosome-inactivating proteins. Battelli MG; Montacuti V; Stirpe F Exp Cell Res; 1992 Jul; 201(1):109-12. PubMed ID: 1612115 [TBL] [Abstract][Full Text] [Related]
13. Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates. Dubé D; Francis M; Leroux JC; Winnik FM Bioconjug Chem; 2002; 13(3):685-92. PubMed ID: 12009963 [TBL] [Abstract][Full Text] [Related]
14. Binding and intracellular routing of the plant-toxic lectins, lanceolin and stenodactylin. Battelli MG; Scicchitano V; Polito L; Farini V; Barbieri L; Bolognesi A Biochim Biophys Acta; 2010 Dec; 1800(12):1276-82. PubMed ID: 20933061 [TBL] [Abstract][Full Text] [Related]
15. Purification of immunotoxins containing the ribosome-inactivating proteins gelonin and momordin using high performance liquid immunoaffinity chromatography compared with blue sepharose CL-6B affinity chromatography. Cumber AJ; Henry RV; Parnell GD; Wawrzynczak EJ J Immunol Methods; 1990 Dec; 135(1-2):15-24. PubMed ID: 2273254 [TBL] [Abstract][Full Text] [Related]
16. Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro. Kamen BA; Smith AK Cancer Chemother Pharmacol; 2012 Jul; 70(1):113-20. PubMed ID: 22644798 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Wang S; Lee RJ; Mathias CJ; Green MA; Low PS Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991 [TBL] [Abstract][Full Text] [Related]
18. Measurement of endosome pH following folate receptor-mediated endocytosis. Lee RJ; Wang S; Low PS Biochim Biophys Acta; 1996 Jul; 1312(3):237-42. PubMed ID: 8703993 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins. Bolognesi A; Tazzari PL; Olivieri F; Polito L; Falini B; Stirpe F Int J Cancer; 1996 Nov; 68(3):349-55. PubMed ID: 8903477 [TBL] [Abstract][Full Text] [Related]
20. Properties of the ribosome-inactivating proteins gelonin, Momordica charantia inhibitor, and dianthins. Falasca A; Gasperi-Campani A; Abbondanza A; Barbieri L; Stirpe F Biochem J; 1982 Dec; 207(3):505-9. PubMed ID: 6819861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]